Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 8,908 | 9,925 | 4,912 | 6,566 | 5,569 |
| Cost of Goods | 259 | 666 | 1,726 | 1,637 | 1,861 |
| Gross Profit | 8,649 | 9,259 | 3,186 | 4,929 | 3,708 |
| Operating Expenses | 37,464 | 38,515 | 38,571 | 37,743 | 34,518 |
| Operating Income | -28,556 | -28,590 | -34,659 | -32,177 | -29,949 |
| Interest Expense | 2,905 | 2,939 | 2,793 | 3,017 | 3,027 |
| Other Income | 1,101 | 1,208 | 1,759 | 2,378 | 2,553 |
| Pre-tax Income | -30,360 | -30,321 | -35,693 | -32,816 | -30,423 |
| Net Income Continuous | -30,360 | -30,321 | -35,693 | -32,816 | -30,423 |
| Net Income | $-30,360 | $-30,321 | $-35,693 | $-32,816 | $-30,423 |
| EPS Basic Total Ops | -0.61 | -0.68 | -0.81 | -0.75 | -0.69 |
| EPS Basic Continuous Ops | -0.61 | -0.68 | -0.81 | -0.75 | -0.69 |
| EPS Diluted Total Ops | -0.61 | -0.68 | -0.81 | -0.75 | -0.69 |
| EPS Diluted Continuous Ops | -0.61 | -0.68 | -0.81 | -0.75 | -0.69 |
| EBITDA(a) | $-25,877 | $-26,302 | $-32,610 | $-30,008 | $-27,721 |